Here are five things to know about the company’s stock.
1. AmSurg stock has posted positive gains of 2.64 percent over the past month, according to the report.
2. This week, AmSurg stock has a consensus rating of “buy.”
3. The company’s stock has a 52-week high of $72.85 and a 52-week low of $45.19.
4. AmSurg stock is up 10.48 percent during the last three months, according to the report.
5. AmSurg has a market cap of $3.4 billion.
More articles on transactions and valuation issues:
5 things to know about Orland Park’s new outpatient center
Buffalo Surgery Center groundbreaking delayed
Backus Center for Specialty Care could include ASC
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
